Investing Profile

Samuel Bjork

VCInvestor
Partner at Digitalis Ventures
Photo of Samuel Bjork, Partner at Digitalis Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Boston Consulting Group (BCG) Network
460 CONNECTIONS
Harvard University Network
146 CONNECTIONS
Zinook Ltd. (Nasdaq: THCG Subsidiary) Network
45 CONNECTIONS
Zinook Ltd. (Nasdaq: THCG Subsidiary) Network
45 CONNECTIONS
University of Cambridge Network
44 CONNECTIONS
cb
$100K - $5.0M
$1.5M
10
$300M
CompanyStageDateRound SizeTotal Raised
EpiBiologics
Series BJan 2026$110M
Series AJul 2023$23M
$200M
Co-investors: Anika Gupta (GV (Google Ventures)), David Schenkein (GV (Google Ventures)), Alexandra Cantley (Polaris Partners), Alaa Halawa (Mubadala), Gaurav Aggarwal (Vivo Capital), Nisa Leung (Qiming Venture Partners), Laura Brass (MPM BioImpact)
T-Therapeutics
Series ANov 2025$32M
Series ANov 2023$60M
$92M
Co-investors: Nihal Sinha (F-Prime Capital Partners), Robert Tansley (Cambridge Innovation Capital), Graziano Seghezzi (Sofinnova Partners)
Judo Bio Inc.
Series AOct 2024$75M
$75M
Bonum Therapeutics
Series ANov 2022$93M
$93M
Co-investors: Monique Schiersing (Roche Venture Fund), John McKearn (RiverVest Venture Partners), Karl Handelsman (Codon Capital)
Good Therapeutics
Series BDec 2021$8M
Series AMay 2020$11M
Series AFeb 2019$11M
$30M
Co-investors: Monique Schiersing (Roche Venture Fund), John McKearn (RiverVest Venture Partners), Karl Handelsman (Codon Capital)
MollyBox
Series BMar 2019$13M
$13M
Researcher + Production Assistant Fourth Floor Productions (Office of Errol Morris)Present
Researcher + Production Assistant Zinook Ltd. (Nasdaq: THCG Subsidiary)Present
Laboratory Research Harvard UniversityPresent
Graduate Research Zinook Ltd. (Nasdaq: THCG Subsidiary)Present
Graduate Research University of CambridgePresent
Project Leader Boston Consulting Group (BCG)Present
Strategic Advisor Columbia Technology VenturesPresent
Partner Digitalis VenturesPresent
Sign in with Google →
Sign in with Google →